Medable Inc., a cloud platform for patient-centered drug development, initiated the first stage of its European expansion with a new EMEA headquarters in Dublin that will serve as a hub for sales, customer service and software development in Europe, enabling Medable to offer digital clinical trials at global scale.
 
The expansion aims to enable greater engagement with hundreds of pharma, biotech and medical device companies across the UK, Germany, Switzerland, Spain, and Benelux. Medable’s European operations will also help support clinical trial deployments in Europe, providing remote and site-based access for patients.
 
Medable has an existing presence in Europe with roughly 60 employees and contractors currently based in the UK, Germany, Denmark, and various other locations in Central and Eastern Europe. The company intends to hire as many as 50 positions in Dublin over the next three years as part of the expansion.
 
“Medable has played a valuable role in making clinical trials more accessible and inclusive for diverse patient populations, and we’re excited to deepen our roots in Europe,” said Dr. Michelle Longmire, CEO and co-founder of Medable. “Our vision for the future of clinical research is based on consumer-scale technology that serves billions of patients through mobile applications and connected devices. We look forward to working with more partners, customers and patients across Europe as we expand our ecosystem and investments.”